What can K Pro do?

K Pro is an advanced drug portfolio decision-making platform that leverages agentic AI to seamlessly connect deep biological understanding with clinically relevant outcomes, enabling pharmaceutical teams to make faster, more confident, and better-informed R&D decisions. Built for accessibility, it empowers both technical and non-technical users to interrogate vast, complex multimodal datasets, including genomic, imaging, clinical, and literature sources, using natural language, eliminating the need for coding or external tools. By integrating high-quality public biomedical databases, proprietary patient data, and user-uploaded data, K Pro breaks down traditional silos and fosters real-time collaboration across research, clinical, and strategic teams. Its three specialized “Agentic Spaces”  Analyze, Activate, and Amplify, support the full drug development lifecycle: from hypothesis generation, biomarker discovery, and mechanistic exploration, to patient population optimization, competitive landscape analysis, and enriched clinical trial evaluation. With capabilities for producing publication-ready visuals, static insight reports, and comprehensive trial data integration, K Pro will function as a collaborative, always-on intelligence layer. All data and operations are underpinned by rigorous privacy, security, and compliance standards, making it a trusted co-pilot for accelerating discovery and de-risking pipeline decisions in modern drug development.

The K Pro free version supports basic functionalities including literature and gap analysis, smart hypothesis testing, scientific writing assistance, and interactive data exploration and visualization, tapping into 17+ biomedical datasets.